AIIMS Creates Record by Completing 100 Four-arm Robotic Surgeries
New Delhi: The All India Institute of Medical Sciences (AIIMS) Friday become the first hospital in Asia to complete 100 surgeries// through the most advanced four-arm robot - Da Vinci S. "We were the first to acquire Da Vinci S robot in July last year and today we completed the 100th operation...Young Survivors of Breast Cancer can Plan a Family After Completing Treatment
Those breast cancer patients who are still young, and have completed their treatment are not required to wait for the stipulated //two years, post-treatment, to plan a family, suggest Australian scientists. Previously, young breast cancer patients were advised to wait for two years before cont...Growing trend of delay in completing vaccination schedule
In the recent issue of Journal of American Medical Association, researchers have pointed out that there seems to be a growing// trend in delaying the vaccination schedules of the children resulting in increase in risk of the vaccinated diseases affecting the children. According to the latest ...Streamline Health Appoints Jon Phillips Chairman of the Board of Directors
...cution of contracts and the related timing of the revenue recognition related thereto, the potential cancellation of existing contracts or clients not completing projects included in the backlog, the impact of competitive products and pricing, product demand and market acceptance, new product development, key s...Valeant Pharmaceuticals Reports Second Quarter Financial Results
...g with its collaboration partner GSK, is still targeting a third quarter 2009 New Drug Application (NDA) submission for retigabine and is committed to completing this event in 2009. The Marketing Authorization Application (MAA) submission is targeted for one month later. 2009 Guidance: The compa...Go Healthy's Marquis Product Cholesterade(R) at Your Fingertips on Google
...e(R), along with the history of its Press Releases and corporate activities, are easily accessible by simply Googling Cholesterade(R). "Whether completing one's due diligence, or searching for recent updates on Go Healthy and/or its products, we are confident that the web content will be of great benefit...ATS Medical Announces Second Quarter 2009 Results
...e ATS 3f(R) portfolio includes offerings at various stages including early product development, pivotal clinical trials, and market commercialization. completing the portfolio in heart valve therapy is the ATS Simulus(R) annuloplasty product line. Simulus products assist the surgeon in repairing a patient's nat...Employers Recognize Potential Impact of Employee Health Management on Future Plan Costs
... to do so next year, said Stafford. Employee incentives to complete health risk appraisals continue to increase notably each year, with incentives for completing health risk appraisals increasing by 130% compared with our 2006 report. Approximately one-third of all employers would like to add such programs in t...BioMarin Announces Second Quarter 2009 Financial Results
...MN-195 - Utrophin upregulator for Duchenne Muscular Dystrophy: BioMarin is completing formulation work and toxicology studies and expects to initiate a Phase I t...is program. BMN-185 - IgA protease for IgA nephropathy: BioMarin is completing early preclinical work and expects to make a decision on the continuation o...Cyberonics Provides Update on Depression Post-Approval Study
... be reasonable. Investors are cautioned that all such statements involve risks and uncertainties, including without limitation, statements concerning completing follow-up on patients enrolled in the D-21 clinical study. Our actual results may differ materially. Important factors that may cause actual results ...Shire Receives Fast Track Designation for velaglucerase alfa for Gaucher Disease
...es the agency to commence its review and proceed on a rolling basis as the additional sections are completed and submitted for review. Shire is completing a phase III clinical program that includes three phase III controlled studies involving over 100 patients at 24 sites in 10 countries around the world...Study shows cancer vaccines led to long-term survival for patients with metastatic melanoma
...trial (64 vs. 31 months, p=.016). Eight patients in the dendritic cell vaccine study experienced remarkable long-term, progression-free survival after completing the vaccine therapy, even though they had widely metastatic disease and/or repeated appearance of new metastases despite various therapies. The vaccin...Scientists track impact of DNA damage in the developing brain
...itor cells, were poised to complete differentiation. In those cells, McKinnon said, loss of Xrcc1 activated the p53 pathway and blocked the cells from completing the cell cycle. "The cells appear to undergo permanent arrest," said McKinnon, noting it is one of the few in vivo examples of the p53 pathway leading...World's largest ocean observatory takes shape
...ld on a 25-year non-stop research expeditioninto the deep ocean. Over the next two-and-a-half months, a team of scientists and marine engineers are completing the installation off the British Columbia coast of NEPTUNE Canada, the world's largest and most advanced cabled ocean observatory. Using three ship...Robo-bats with metal muscles may be next generation of remote control flyers
...e fully assembled skeleton rests easily in the palm of your hand and, at less than 6 grams, feels as light as a feather. The researchers are currently completing fabrication and assembly of the joints, muscular system and wing membrane for the robo-bat, which should allow it to fly with the same efficient flapp...Ferns took to the trees and thrived
...ring of their own species diversity. "The canopy is there and -- boom -- diversification," said Duke University researcher Eric Schuettpelz, who is completing a post-doctoral fellowship in biology with associate professor Kathleen Pryer. By integrating genomic data from 400 living fern species with inform...Clinical trials for shingles drug take an important step forward
...ported no serious adverse events in healthy volunteers and data supported the potential for once-a-day dosing in future trials. Inhibitex anticipates completing its first Phase II trial of FV-100 in the first half of 2010. Russell H. Plumb, president and chief executive officer of Inhibitex, Inc said: "We ...Limping rat provides sciatica insights
...rthritis and asthma. "This finding suggests a possible role for immune system activation in contributing to symptoms of sciatica," said Shamji, now completing his neurosurgical residency at the Ottawa Hospital in Canada. "This offers new insight into the pathophysiology of the disease, and may also identify...Genome projects launched for three extreme-environment animals
...king it a key model animal to investigate mammalian hypoxia adaptability. The launch of these sequencing projects not only fills taxonomic gaps for completing an extensive and detailed complete genomic picture for the Tree of Life project that was previously launched at BGI-Shenzhen, it also provide an essen...A genomic CluE for cloud computing
...the more difficult task of determining all possible combinations of the loosely fitting pieces and finding the best one. Pop likens this process to completing a jigsaw puzzle. "If you have a reference genome, it's like having the box with the picture on the front to guide your assembly," he said. "With no ...Allscripts Integrates Electronic Health Records with Innovative Patient Kiosk
...ctices a full-service kiosk package, from initial design through development, deployment and maintenance. "Patients want to remove the pain of completing paper forms during every visit and physician practices want nothing more than to find better, faster, more effective ways to complete accurate patient...Viral Genetics Creates Subsidiary to Develop Cancer Therapy
...nology from the University of Vermont and the University of Colorado, where the technology was invented and developed by Dr. Newell. Viral Genetics is completing negotiations to convert the option into an exclusive worldwide license covering a broad range of uses and specific therapeutic compositions. Up...Microbix Sales Grow 22% For Nine Months
...collaborations with partners," Mr. Gastle said. "The Company is engaged in three activities including performance testing with H1N1 yield enhancement, completing financing for the influenza vaccine manufacturing facility in Hunan China, and the scale up of the VIRUSMAX technology under commercial conditions. Mi...Optimer Pharmaceuticals Reports Second Quarter 2009 Financial Results
... "As we head into the second half of this year, we look forward to presenting additional data from this study at ICAAC and IDSA and we are focused on completing our second fidaxomicin Phase 3 trial and preparing regulatory filings for fidaxomicin and prulifloxacin." Recent Corporate Highlights ...TorreyPines Cancels Special Meeting of Stockholders in Order to Pursue Merger Transaction
...n Agreement and Plan of Merger by and between TPTX and Raptor Pharmaceuticals Corp., TPTX's Board approved cancelling the meeting in order to focus on completing the merger transaction. In connection with the proposed merger described above, TorreyPines will file a registration statement on Form S-4 that...Atherotech Taps Canyons Medical Center Director, Lipidologist as Chief Medical Officer
... Lipid Association. He is also a member of the American Society of Hypertension and is recognized as a clinical hypertension specialist. Since completing medical school and residency in the early '90s, he has obtained a master's degree in psychopharmacology, and his practice is a referral clinic for the...Peregrine Pharmaceuticals Licenses Anti-VEGF Antibodies to Affitech
...me market analysts. Factors that could cause actual results to differ materially include, but are not limited to, uncertainties associated with completing preclinical and clinical trials for our technologies; the early stage of product development; the significant costs to develop our products as all of ...